immunogenicity and safety of purified vero-cell rabies vaccine in severely rabies-exposed patients in china. | the immunogenicity and safety of a purified vero-cell rabies vaccine (pvrv, verorab; aventis pasteur, france) were evaluated in 171 patients treated for severe exposure to rabies (who category iii contacts) at the shandong provincial antiepidemic station in jinan and an epi center in ping yin, china. post-exposure treatment consisted of a single dose of equine rabies immunoglobulin (erig, 40 iu/kg body weight) on day (d) 0, and intra-muscular administration of pvrv on d 0, 3, 7, 14 and 28. antir ... | 2000 | 11127328 |